Exploration of a xenograft model of human prostate cancer to predict patient treatment response
For several years, docetaxel was the only treatment to improve survival of patients with metastatic prostate cancer. There are now many novel agents available but the optimal sequence of treatments remains undefined. The emergence of prostate cancer stem cells has brought a new way to elucidate the...
Main Author: | Beekharry, Ramprakash |
---|---|
Published: |
University of Hull
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.679629 |
Similar Items
-
A model for the modulation of cancer chemotherapy using human tumour xenografts
by: Carmichael, James
Published: (1986) -
Experimental studies on prediction of response to cancer treatment
by: Ramsay, Jonathan R.
Published: (1997) -
Procoagulants, coagulopathy and prostate cancer
by: Adamson, Andrew Stephen
Published: (1992) -
Predicting prognosis and drug response in breast cancer
by: Holt, S.
Published: (1984) -
Expression of matrix metalloproteinases and their inhibitors in prostate cancer
by: Still, Karen
Published: (1997)